Cefapirin Sodium

头孢匹林钠

Report date: 2023/06/09 20:00:36
NME

Base Information

Drug NameCefapirin Sodium
Drug Alias Name头孢菌素cefapirinumcephapirin sodium头孢吡硫先锋霉素Ⅷ +[11] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsCholecystitis, AcuteBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesHong Kong
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesChinese University Of Hong Kong (Cuhk)
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsCholecystitis, Acute
Inactive IndicationsBacterial Infections

Other Information

ATC CodeJ01DB08
Related LinksWikipediaDrugBankKEGG